Avista Healthcare Public Acquisition, a blank check company formed by Avista to acquire a health care company, filed and announced terms for its IPO on Friday.
The New York, NY-based company plans to raise $300 million by offering 30 million shares at a price of $10 . At the proposed price, Avista Healthcare Public Acquisition would command a fully diluted market value of $375 million.
Avista Healthcare Public Acquisition was founded in 2015 and plans to list on the Nasdaq under the symbol AHPAU. Credit Suisse is the sole bookrunner on the deal. A pricing date has not yet been disclosed.
